Regulus Therapeutics Inc (NASDAQ:RGLS)

2.04
BATS BZX Real-Time Price
As of 1:50pm ET
 -0.015 / -0.73%
Today’s Change
1.58
Today|||52-Week Range
8.72
-35.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues20.8M1.2M72.0K72.0K
 
 
 
 
 
Depreciation And Amortization1.6M2.3M2.5M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses73.9M80.4M67.7M43.8M
 
 
 
 
 
Research And Development56.4M64.3M53.2M33.1M
 
 
 
 
 
Total Operating Expenses75.5M82.7M70.2M46.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.8M-81.5M-70.1M-46.0M
 
 
 
 
 
Extraordinary Charge-1.8M0.000.00-800.0K
 
 
 
Interest Expense On Debt52.0K1.2M2.7M2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-55.8M-81.8M-72.1M-48.6M
 
 
 
 
 
Income Taxes-18.0K-4.0K-197.0K-62.0K
 
 
 
 
 
Net Income-55.7M-81.8M-71.9M-48.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.3M4.4M6.3M8.7M
 
 
 
 
 
Shares To Calculate EPS Diluted4.3M4.4M6.3M8.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$12.96-$18.60-$11.52-$5.59
 
 
 
 
 
EPS Diluted-$12.96-$18.60-$11.52-$5.59